Prevalence of OmpK35 and OmpK36 porin expression in beta-lactamase and non-beta-lactamase-producing Klebsiella pneumoniae

Biologics: Targets and Therapy

Volumn 6, Issue , 2012, Pages 1-4

  Shakib, Pegah ^a,b   Ghafourian, Sobhan ^a   Zolfaghary, Mohammad Reza ^b   Hushmandfar, Reza ^c   Ranjbar, Reza ^d   Sadeghifard, Nourkhoda ^a  

^a ILAM UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ISLAMIC AZAD UNIVERSITY   (Iran)

^c ILAM UNIVERSITY   (Iran)

^d BAQIYATALLAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Extended spectrum beta lactamase producing strains; Klebsiella pneumoniae; Porin expression

Indexed keywords

ANTIINFECTIVE AGENT; BETA LACTAMASE; CEFOTAXIME; CEFTAZIDIME; CEFTRIAXONE; CEPHALOSPORIN; OMPK35 PORIN; OMPK36 PORIN; PORIN; UNCLASSIFIED DRUG;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; CONTROLLED STUDY; DRUG CHOICE; EXTENDED SPECTRUM BETA LACTAMASE PRODUCING KLEBSIELLA PNEUMONIAE; KLEBSIELLA PNEUMONIAE; NON EXTENDED SPECTRUM BETA LACTAMASE PRODUCING KLEBSIELLA PNEUMONIAE; NONHUMAN; PROTEIN EXPRESSION;

EID: 84856661302     PISSN: 11775475     EISSN: 11775491     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Urban C, Rahal JJ. Klebsiella and extended spectrum β-lactamases. Int J Antimicrob Agents. 1997;8:37-43.
2. Poole K. Resistance to beta-lactam antibiotics. Cell Mol Life Sci. 2004;61: 2200-2223.
3. Majiduddin FK, Materon IC, Palzkill GT. Molecular analysis of beta-lactamase structure and function. J Med Microbiol. 2002;292:127-137.
4. Domenech SA, Hernandez AS, Martinez L, Benedi VJ, Alberti S. Identifcation and characterization of a new porin gene of Klebsiella pneumoniae: its role in B-lactam antibiotic resistance. J Bacteriol. 1999;181: 2726-2732.
5. Hernandez AS, Albertí S, Alvarez D, et al. Porin expression in clinical isolates of Klebsiella pneumoniae. Microbiology. 1999;145:673-679.
6. Martínez ML, Pascual A, Conejo MC, et al. Energy-dependent accumulation of norfoxacin and porin expression in clinical isolates of Klebsiella pneumoniae and relationship to extended-spectrum beta-lactamase production. Antimicrob Agents Chemother. 2002;46:3926-3932.
7. Martínez ML, Pascual A, Hernandez AS, et al. Roles of B-lactamases and porins in activities of carbapenems and cephalosporins against Klebsiella pneumoniae. Antimicrob Agents Chemother. 1999;43:1669-1673.
8. Siu LK. Is OmpK35 specific for ceftazidime penetration? Antimicrob Agents Chemother. 2001;45:1601-1602.
9. Bauer AW, Kirby WM, Sherris JC, Turck M. Antibiotic susceptibility testing by a standardized single disk method. Am J Clin Pathol. 1966;45: 493-496.
10. Wayne PA. Performance standards for antimicrobial susceptibility testing. Twentieth informational supplement, Clinical and Laboratory Standards Institute; 2010:M100-S20. Available from: www.clsi.org/ source/orders/free/m100-s21.pdf. Accessed December 6, 2011.
11. Hernández AS, María CC, Pascualb A, Tomásc JM, Benedía VJ, Martínez ML. Relationship between outer membrane alterations and susceptibility to antimicrobial agents in isogenic strains of Klebsiella pneumoniae. J Antimicrob Chemother. 2000;46:273-277.
12. Ardanuy C. Outer membrane profiles of clonally related Klebsiella pneumoniae isolates from clinical samples and activities of cepha-losporins and carbapenems. Antimicrob Agents Chemother. 1998;42: 1636-1640.
13. Nikaido H. Outer membrane barrier as a mechanism of antimicrobial resistance. Antimicrob Agents Chemother. 1989;33:1831-1836.
14. Sanchez DA. Activity of nine antimicrobial agents against clinical isolates of Klebsiella pneumoniae producing extended-spectrum beta-lactamases and deficient or not in porins. J Antimicrob Chemother. 2000;46:858-860.